1. Home
  2. ENVB vs BOXL Comparison

ENVB vs BOXL Comparison

Compare ENVB & BOXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENVB
  • BOXL
  • Stock Information
  • Founded
  • ENVB 1994
  • BOXL 1985
  • Country
  • ENVB United States
  • BOXL United States
  • Employees
  • ENVB N/A
  • BOXL N/A
  • Industry
  • ENVB Biotechnology: Pharmaceutical Preparations
  • BOXL Telecommunications Equipment
  • Sector
  • ENVB Health Care
  • BOXL Telecommunications
  • Exchange
  • ENVB Nasdaq
  • BOXL Nasdaq
  • Market Cap
  • ENVB 3.2M
  • BOXL 3.3M
  • IPO Year
  • ENVB N/A
  • BOXL 2017
  • Fundamental
  • Price
  • ENVB $1.28
  • BOXL $1.50
  • Analyst Decision
  • ENVB Strong Buy
  • BOXL Buy
  • Analyst Count
  • ENVB 1
  • BOXL 3
  • Target Price
  • ENVB $10.00
  • BOXL $5.00
  • AVG Volume (30 Days)
  • ENVB 42.6K
  • BOXL 18.5K
  • Earning Date
  • ENVB 05-19-2025
  • BOXL 05-20-2025
  • Dividend Yield
  • ENVB N/A
  • BOXL N/A
  • EPS Growth
  • ENVB N/A
  • BOXL N/A
  • EPS
  • ENVB N/A
  • BOXL N/A
  • Revenue
  • ENVB N/A
  • BOXL $135,893,000.00
  • Revenue This Year
  • ENVB N/A
  • BOXL N/A
  • Revenue Next Year
  • ENVB N/A
  • BOXL $1.12
  • P/E Ratio
  • ENVB N/A
  • BOXL N/A
  • Revenue Growth
  • ENVB N/A
  • BOXL N/A
  • 52 Week Low
  • ENVB $1.01
  • BOXL $1.06
  • 52 Week High
  • ENVB $222.75
  • BOXL $10.65
  • Technical
  • Relative Strength Index (RSI)
  • ENVB 31.74
  • BOXL 47.26
  • Support Level
  • ENVB $1.23
  • BOXL $1.43
  • Resistance Level
  • ENVB $1.40
  • BOXL $1.61
  • Average True Range (ATR)
  • ENVB 0.09
  • BOXL 0.13
  • MACD
  • ENVB 0.15
  • BOXL 0.01
  • Stochastic Oscillator
  • ENVB 48.15
  • BOXL 20.00

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

About BOXL Boxlight Corporation

Boxlight Corp is a technology company that develops, sells and services interactive solutions predominantly for the education market, but also for the corporates and government sectors. The company currently designs, produces and distributes interactive technologies including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras and other peripherals for the education market and non-interactive solutions including flat panels, LED video walls and digital signage. The company also distributes science, technology, engineering and math (or STEM) products, including 3D printing and robotics solutions, and a portable science lab.

Share on Social Networks: